You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vaccines, DNA

Showing 1 - 25 of 6,903
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Castration-resistant Prostate Cancer, Metastatic Cancer, Prostate Cancer Trial in Saint Louis, Madison (pTVG-HP, pTVG-AR,

Recruiting
  • Castration-resistant Prostate Cancer
  • +2 more
  • pTVG-HP
  • +2 more
  • Saint Louis, Missouri
  • +1 more
Nov 21, 2022

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Soft Tissues Trial

Active, not recruiting
Has Results
  • Hormone-Resistant Prostate Cancer
  • +6 more
  • Pembrolizumab
  • pTVG-HP Plasmid DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 8, 2022

HIV Trial in Boston (env (A,B,C,A/E)/gag (C) DNA Vaccine, gp120 (A,B,C,A/E) Protein Vaccine, GLA-SE adjuvant)

Active, not recruiting
  • HIV Infections
  • env (A,B,C,A/E)/gag (C) DNA Vaccine
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jun 8, 2022

SARS-CoV2 COVID-19 Trial in Randwick, Adelaide, Perth (COVIGEN C19 0.8 mg ID or Placebo ID, COVIGEN C19 2.0 mg IM or Placebo IM,

Active, not recruiting
  • SARS-CoV2 COVID-19
  • COVIGEN C19 0.8 mg ID or Placebo ID
  • +3 more
  • Randwick, New South Wales, Australia
  • +2 more
Nov 17, 2022

SARS-CoV2 Infection Trial (GX-19N, Placebo)

Withdrawn
  • SARS-CoV2 Infection
  • GX-19N
  • Placebo
  • (no location specified)
Apr 4, 2022

HIV Trial (GEO-D03 DNA Vaccine, MVA/HIV62B Vaccine, Placebo for DNA GEO-D03)

Withdrawn
  • HIV Infections
  • GEO-D03 DNA Vaccine
  • +3 more
  • (no location specified)
Nov 4, 2021

HIV Trial in Kericho (Env-C Plasmid DNA, HIV Env gp145 C.6980 protein, Rehydragel®)

Active, not recruiting
  • HIV Infections
  • Env-C Plasmid DNA
  • +6 more
  • Kericho, Kenya
    Kenya Medical Research Institute/Walter Reed Project, Clinical R
Feb 25, 2022

COVID-19, Infection Viral, Infections Trial in Bergen, Oslo (VB10.2129, VB10.2210)

Active, not recruiting
  • COVID-19
  • +2 more
  • VB10.2129
  • VB10.2210
  • Bergen, Norway
  • +1 more
Jan 6, 2023

HIV Trial in United States (AIDSVAX B/E Vaccine, DNA-HIV-PT123 Vaccine, Placebo for DNA-HIV-PT123)

Completed
  • HIV Infections
  • AIDSVAX B/E Vaccine
  • +3 more
  • San Francisco, California
  • +6 more
Oct 13, 2021

HIV Trial in United States (GEO-D03 DNA vaccine, MVA/HIV62B (MVA62B) vaccine, Placebo for GEO-D03 DNA)

Completed
  • HIV Infections
  • GEO-D03 DNA vaccine
  • +3 more
  • Birmingham, Alabama
  • +3 more
Oct 13, 2021

HIV Trial in Switzerland, United States (DNA Nat-B env, DNA CON-S env, DNA Mosaic env)

Completed
  • HIV Infections
  • DNA Nat-B env
  • +7 more
  • Birmingham, Alabama
  • +6 more
Oct 13, 2021

Prostate Cancer Trial in Madison (pTVG-HP, Nivolumab, GM-CSF)

Active, not recruiting
  • Prostate Cancer
  • pTVG-HP
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Feb 7, 2022

HIV Trial in United States (PENNVAX®-GP HIV-1 DNA vaccine, Interleukin-12 (IL-12) DNA adjuvant, Placebo)

Completed
  • HIV Infections
  • PENNVAX®-GP HIV-1 DNA vaccine
  • +2 more
  • Decatur, Georgia
  • +3 more
Oct 13, 2021

HIV Trial in Badalona (DNA.HTI 0.5mL at weeks 0, 4 and 8 + MVA.HTI 0.5mL at weeks 12 and 20 (DDDMM), At least 24 weeks since

Completed
  • HIV
  • DNA.HTI 0.5mL at weeks 0, 4 and 8 + MVA.HTI 0.5mL at weeks 12 and 20 (DDDMM)
  • +2 more
  • Badalona, Barcelona, Spain
    IrsiCaixa AIDS Research Institute, Hospital Universitari Germans
Apr 7, 2021

HIV Trial in United States (DNA Vaccine, DNA Vaccine , rAd35)

Completed
  • HIV Infections
  • DNA Vaccine
  • +5 more
  • Birmingham, Alabama
  • +9 more
Oct 13, 2021

HIV Trial (DNA-HIV-PT123, NYVAC-HIV-PT1, NYVAC-HIV-PT4)

Withdrawn
  • HIV Infections
  • DNA-HIV-PT123
  • +4 more
  • (no location specified)
Oct 13, 2021

Malaria Trial in Silver Spring (DNA vaccine prime, adenovirus type 5 vaccine boost)

Completed
  • Malaria
  • DNA vaccine prime
  • adenovirus type 5 vaccine boost
  • Silver Spring, Maryland
    Clinical Trials Center, WRAIR
Feb 10, 2021

HIV Trial in Boston, Johannesburg, Cape Town (Sub C gp140 Vaccine, MF59C.1 Adjuvant, Sodium chloride)

Completed
  • HIV Infections
  • Sub C gp140 Vaccine
  • +2 more
  • Boston, Massachusetts
  • +3 more
Oct 13, 2021

HIV Trial in United States (HIV-MAG vaccine, IL-12 pDNA adjuvant, VSV HIV gag vaccine)

Completed
  • HIV Infections
  • HIV-MAG vaccine
  • +4 more
  • New York, New York
  • +4 more
Oct 13, 2021

HIV Trial in United States (DNA plasmid vaccine, Recombinant adenoviral serotype 5 (rAD5) vector vaccine, DNA vaccine )

Terminated
Has Results
  • HIV Infections
  • DNA plasmid vaccine
  • +3 more
  • Birmingham, Alabama
  • +21 more
Oct 13, 2021

Prostate Cancer Trial in New Brunswick, Seattle, Madison (pTVG-AR, gm-csf)

Completed
  • Prostate Cancer
  • pTVG-AR
  • gm-csf
  • New Brunswick, New Jersey
  • +2 more
Feb 2, 2021

Acute Respiratory Viral Infection Trial in Russian Federation (Raphamin, Placebo)

Recruiting
  • Acute Respiratory Viral Infection
  • Ekaterinburg, Russian Federation
  • +30 more
Jan 20, 2023

Influenza A, Pandemic Influenza Trial in Oslo (H7HLAII)

Recruiting
  • Influenza A
  • Pandemic Influenza
  • H7HLAII
  • Oslo, Norway
    Oslo University Hospital
Sep 20, 2023

Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine

Active, not recruiting
  • Chronic Hepatitis
  • Hepatitis C Infection
  • Electroporation-Mediated Plasmid DNA Vaccine Therapy
  • +4 more
  • Jacksonville, Florida
  • +4 more
Sep 20, 2022

HIV Trial in Birmingham, San Francisco, Seattle (pGA2/JS2 Plasmid DNA Vaccine)

Completed
  • HIV Infections
  • pGA2/JS2 Plasmid DNA Vaccine
  • Birmingham, Alabama
  • +3 more
Oct 13, 2021